×

Suh JW, Lee SP, Park KW, et al. Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease. J Am Coll Cardiol. 2011;57:280-9. 관상동맥 스텐트 삽입 후 항혈소판제제에 대한 반응이 환자마다 다양하며, 이러한 반응 차이가 시술 후 경과를 결정짓는 주요 인자임을 규명.

Suh JW, Mehran R, Claessen BE, et al. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2011;58:1750-6.심근경색 환자 치료 과정에서 생기는 출혈 합병증이 환자의 장기 경과에 중대한 영향을 미치는 위험 인자임을 규명.

Suh JW, Koo BK, Zhang SY, et al. Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. CMAJ 2006; 174:1715-22.

Suh JW, Park JS, Cho HJ, et al. Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans. Int J Cardiol 2007;117:31-6.

Suh JW, Baek SH, Park JS, et al. Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study. Am Heart J 2009;157:908-12.

Choi DH, Suh JW (co-first author), Park KW, et al. Pilot, open-label, prospective, randomized assessment of the bioequivalence of the original and a generic formulation of abciximab in Korean patients with acute coronary syndrome. Clin Ther 2009;31:1804-11.

Suh JW, Kim SY, Park JS, et al. Comparison of triple antiplatelet therapy including triflusal and conventional dual therapy in patients who underwent drug-eluting stent implantation. Int Heart J 2009;50:701-9.

Suh JW, Choi DJ, Chang HJ, et al. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase. J Korean Med Sci 2010;25:16-23.

Suh JW, Chung WY, Kim YS, et al. The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention. Int J Cardiol. 2010 Mar 1. [Epub ahead of print]

Lee SP, Suh JW (co-first author), Park KW, et al. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease. Trials 24;11:87.

Suh JW, Seung KB, Gwak CH, et al. Comparison of antiplatelet effect and tolerability of clopidogrel resinate with clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD-equivalent risks: a phase IV, prospective, double-dummy, parallel-group, 4-week noninferiority trial. Clin Ther. 2011;33:1057-68.

Kang SH, Suh JW, Yoon CH, et al. Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry). Am J Cardiol. 2012;109:787-93.

Suh JW, Kim CH, Oh IY, et al. Effect of Tailored Antiplatelet Therapy on Periprocedural Myonecrosis in Patients With Diabetes Mellitus (from the DM-VerifyNow Trial). Am J Cardiol. 2012;110:1749-55.

Cho I, Suh JW, Chang HJ, et al. Prevalence and prognostic implication of non-calcified plaque in asymptomatic population with coronary artery calcium score of zero..Korean Circ J. 2013;43:154-60.

Kim YG, Suh JW (corresponding author), Yoon CH, et al. Platelet Volume Indices are Associated with High Residual Platelet Reactivity after Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention. J Atheroscler Thromb. 2014 Jan 15. [Epub ahead of print]

Suh JW, Yoon YE, Oh IY, et al. A single-center prospective randomized controlled trial evaluating the safety and efficacy of IntraCoronary Erythropoietin delivery BEfore Reperfusion: gauging infarct size in patients with acute ST-segment elevation myocardial infarction. Study design and rationale of the 'ICEBERG Trial'. Contemp Clin Trials. 2013;35:145-50.